Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
J Clin Invest
    April 2018
  1. YU J, Qin B, Moyer AM, Nowsheen S, et al
    DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.
    J Clin Invest. 2018 Apr 30. pii: 97924. doi: 10.1172/JCI97924.
    >> Share

  2. CHEN Y, Zhang B, Bao L, Jin L, et al
    ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.
    J Clin Invest. 2018 Apr 9. pii: 95089. doi: 10.1172/JCI95089.
    >> Share

    March 2018
  3. BAO L, Qian Z, Lyng MB, Wang L, et al
    Coexisting genomic aberrations associated with lymph node metastasis in breast cancer.
    J Clin Invest. 2018 Mar 15. pii: 97449. doi: 10.1172/JCI97449.
    >> Share

    February 2018
  4. SIEGEL MB, He X, Hoadley KA, Hoyle A, et al
    Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer.
    J Clin Invest. 2018 Feb 26. pii: 96153. doi: 10.1172/JCI96153.
    >> Share

  5. ZHAO N, Cao J, Xu L, Tang Q, et al
    Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.
    J Clin Invest. 2018 Feb 26. pii: 95873. doi: 10.1172/JCI95873.
    >> Share

  6. ULLAH I, Karthik GM, Alkodsi A, Kjallquist U, et al
    Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes.
    J Clin Invest. 2018 Feb 26. pii: 96149. doi: 10.1172/JCI96149.
    >> Share

    December 2017
  7. SUN Q, Lesperance J, Wettersten H, Luterstein E, et al
    Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis.
    J Clin Invest. 2017 Dec 11. pii: 93707. doi: 10.1172/JCI93707.
    >> Share

    November 2017
  8. MISHRA P, Tang W, Putluri V, Dorsey TH, et al
    ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming.
    J Clin Invest. 2017 Nov 27. pii: 93815. doi: 10.1172/JCI93815.
    >> Share

  9. WANG S, Liang K, Hu Q, Li P, et al
    JAK2-binding long noncoding RNA promotes breast cancer brain metastasis.
    J Clin Invest. 2017 Nov 13. pii: 91553. doi: 10.1172/JCI91553.
    >> Share

    August 2017
  10. TAYLOR NA, Vick SC, Iglesia MD, Brickey WJ, et al
    Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.
    J Clin Invest. 2017 Aug 21. pii: 90499. doi: 10.1172/JCI90499.
    >> Share

  11. LI W, Zhang Z, Liu X, Cheng X, et al
    The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer.
    J Clin Invest. 2017 Aug 14. pii: 94233. doi: 10.1172/JCI94233.
    >> Share

  12. JESCHKE J, Bizet M, Desmedt C, Calonne E, et al
    DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
    J Clin Invest. 2017;127:3090-3102.
    >> Share

    May 2017
  13. HAVAS KM, Milchevskaya V, Radic K, Alladin A, et al
    Metabolic shifts in residual breast cancer drive tumor recurrence.
    J Clin Invest. 2017 May 15. pii: 89914. doi: 10.1172/JCI89914.
    >> Share

    April 2017
  14. ZHANG L, Cai M, Gong Z, Zhang B, et al
    Geminin facilitates FoxO3 deacetylation to promote breast cancer cell metastasis.
    J Clin Invest. 2017 Apr 24. pii: 90077. doi: 10.1172/JCI90077.
    >> Share

    November 2016
  15. SIGNORETTI S, Di Marcotullio L, Richardson A, Ramaswamy S, et al
    Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.
    J Clin Invest. 2016;126:4387.
    >> Share

    August 2016
  16. JONES RA, Robinson TJ, Liu JC, Shrestha M, et al
    RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.
    J Clin Invest. 2016 Aug 29. pii: 81568. doi: 10.1172/JCI81568.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016